Serious Disease Genetic Testing Claims More Likely To Prompt FTC Action

The Federal Trade Commission's limited oversight of regional laboratories and genetic test promotional claims for non-life-threatening diseases is eliciting concern from the HHS Secretary's Advisory Committee on Genetics, Health & Society